Skip to main content
HHS logo

HHS · Harte Hanks Inc

Track HHS — free
$4.47 -0.07 (-1.54%)
Market Cap
$34.29M
Shares
7.45M
Volume · Oct 6 112.14K Avg daily vol (3M) 163.5K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$4.54 Open$4.59 Day$4.54–4.59 52W close$2.00–4.65 Avg vol 30d96K Short int33K · 0.4% float · 1.0d Short vol19% Last earningsMay 14, 2026 DataJan 2020–Oct 2026 Filing10-Q · Aug 14

Up next

filed Aug 14, 2026
call held Nov 15, 2024

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$154.63M
Trailing 12 months
Net income (TTM)
−$5.71M
Trailing 12 months
Revenue growth YoY
-1.7%
Year over year
Operating margin
-3.1%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+0.7%
Year over year · more shares
Price change (1Y)
+24.3%
Trailing year
Short interest
0.4%
Latest settlement · 1.0 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Buy Momentum Very Strong Sentiment Neutral Fundamentals Strong Quant / Vol Very High
Market backdrop VIX 15.5 · calm Equity put/call 0.59
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +51%
above
Price vs 50-day avg +20%
above
RSI (14) 64
neutral
MACD trend Negative
52-week position 96%
near high
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Strong
1-month return +6%
trailing
6-month return +82%
trailing
YTD return +51%
this year
Relative strength +70%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $4 › 200d $3 — 50d above 200d
Institutional flow Flat
0% holders QoQ · +1 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.44% of float · ▼ -50.9% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
22 holders — near 3-yr low, contrarian setup
Squeeze score 40
elevated · 0–100
Fundamentals
Strong
Revenue growth −14%
Y/Y
EPS growth +97%
Y/Y
Free cash flow $-4.5M
Buyback $4.1M
remaining
Balance sheet $6.9M
net cash
Quant / Vol
risk profile
Very High
Volatility 79%
annualized · 1-yr
Max drawdown −49%
past year
ATR 2.6%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the 8-K filed Mar 18, 2024
Cost reductions · over next two years $16M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
1 · 3 · 3
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+51% Bullish
Price vs 50-day avg
+20% Bullish
RSI (14)
64 Neutral
MACD trend
Negative Bearish
52-week position
96% Bullish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross) No cross
50d $4 › 200d $3 — 50d above 200d
Institutional flow Flat
0% holders QoQ · +1 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.44% of float · ▼ -50.9% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
22 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $2 Now $5 · 96% Range high $5
vs 200-day avg +51% vs 50-day avg +20%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Conglomerates — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
HHS
Harte Hanks Inc
this stock
$34.29M +50.8% -13.9% — 0.4%
HTHIY
Hitachi Ltd
$158.53B +15.2% — — 0.0%
ITOCF
Itochu Corp
$101.56B +4.2% — — 0.2%
MMM
3M Co
$87.44B +1.9% +1.5% 30.1 1.9%
HON
Honeywell International Inc
$67.37B — +12.9% — 2.3%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
22
% held
27.9%
Net QoQ
+4.2K sh
Top holder
BLAIR WILLIAM & CO/IL
Held Float
View
Held by Funds
Fund positions
17
View
Short & Settlement
Short Interest Falling
Shares short
32.8K
Days to cover
1.0d
Change
-34.1K sh
View
Short Volume
Short vol %
19%
As of
Oct 5, 2026
Short Total
View
Fails to Deliver
FTD shares
926
Value
$3.9K
As of
Aug 27, 2026
View
Off-Exchange
Off-exchange %
35.2%
Week of
Aug 31, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$159.6M
Net income (FY)
$-811.0K
EPS diluted
$-0.11
View
Buybacks
Authorized
$6.5M
Remaining
$4.1M
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Sep 15, 2026
This year
9
View
Earnings & Events
Webcasts
Last webcast
May 14, 2026
View

Performance

5D 20D 120D MTD YTD
HHS -1.3% +6.3% +81.6% -0.2% +50.8%
SPY +1.2% +0.6% +11.6% +1.6% +13.6%
vs SPY -2.5% +5.7% +70.0% -1.8% +37.2%

Capital returns

Buyback program · as of Jun 30, 2026
Authorized
$6.50M
Spent (derived)
$2.40M
Remaining
$4.10M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 45919 CUSIP 416196202 13F (30d) 1 filings 1 filers Visit website Investor relations